Explanipedia

Building global development strategies for cf therapeutics during a transitional cftr modulator era Open

Nicole Mayer-Hamblett, Silke van Koningsbruggen‐Rietschel, David P. Nichols, Donald R. VanDevanter, Jane C. Davies , et al. · 2020

Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities Open

Dave P. Nichols, Anthony G. Durmowicz, A G Field, Patrick A. Flume, Donald R. VanDevanter , et al. · 2019

CFTR modulator theratyping: Current status, gaps and future directions Open

John P. Clancy, Calvin U. Cotton, Scott H. Donaldson, George M. Solomon, Donald R. VanDevanter , et al. · 2018

Cystic fibrosis biomarker — Commentary Open

Anthony G. Durmowicz · 2016

CF end point commentary Open

Anthony G. Durmowicz · 2016

Anthony G. Durmowicz YOU? Author Swipe